Several studies have evidently shown that chemokines (such as CCL2, CCL5, CXCL1, and CX3CL1) are involved in neuronal sensitization or microglia activation in the spinal cord, and some of these chemokines contribute to the development of cancer pain [62, 63]. Here, CCL2 is linked to cancer.